Automating LC-Based N-Glycan Analysis for CMC
Automated Assay Analytics from Discovery to CMC
Deriving an RNA Quality Scoring Method Applicable to a broad Range of Instruments
From Screening to Sequencing: Digital Backbone for Antibody Discovery
Accelerating CMC with NGS through AI-Driven and GMP-Compliant Digital Infrastructure
Integrated Workflow for SPR-Based Biotherapeutic Characterization
Rapid Intact Mass Screening: One-Second per Well
Multi-Omics Analysis for Resistance Mode-of-Action Discovery
Visualization of Pangenome Data for Crop Breeding R&D
Request Management Module to Increase Biotherapeutics R&D Operational Efficiency
Automating Chromatography & Electrophoresis Data Workflows
Digitalizing Trait Stability in Plant Breeding
Automating Analysis of Large-Scale Data for Flow Cytometry Screening
Analysis of Label-Free Live Cell Imaging Using AI
Unsupervised Phenotype Discovery in High-Content Imaging via Archetypes and Self-Supervised Learning
Agentic AI Enables Automated CellProfiler Pipeline Design via Multimodal In-Context Learning
Automated Analysis of High-Throughput Protein Stability For Antibody Developability Assessment
Digitalizing CMC Processes at Novartis
End-to-End Sample Management Solution
Enhancing Gene Therapy Assets with GMP-Ready NGS Assays
Workflow Automation for High-Throughput Spectral Shift Analysis
NGS-Powered CMC Strategies
Biotherapeutics Development with NGS Assays In-House
HT-MS Analytics for ML/AI-Ready Drug Discovery
Structured Knowledge Mgmt Platform for Bioprocess Development
Turning Data into Decisions: RAS Inhibitor Case Study
Untargeted HILIC Metabolomics of Soybean Amino Acid Pathways
New Peak Detection Workflow for MAM Implementation
Boosting Efficiency in High-Throughput Intact Mass Spectrometry
Automated Workflow for Oligonucleotide Mass Mapping
Automated Peptide Mapping for Higher Throughput
Integrated Assay Analysis for Antibody Developability
Digital Platform for the Development of Next-Generation ADCs
Automated HT-Engineering Platform for AI-Supported Developability Predictions
Accelerating Biopharmaceutical and Vaccine Research, Discovery, and Development
NGS for CMC of Gene and Cell Therapy Products
Long-Read NGS for QC in CGTs Manufacturing
Do's and Don'ts of CSV for In-House NGS-Based Biosafety Assays
Platform for Streamlined LC/MS-based MAM Implementation
MS Analytics Platform for Emerging Therapeutic Modalities
